← Product Code [IPF](/productcode/IPF) · K980892

# HAKOMED ELECDT / PRO ELEDT SERIES (K980892)

_Alive, Inc. · IPF · May 11, 1998 · Physical Medicine · SESE_

**Canonical URL:** https://fda-staging.innolitics.com/device/K980892

## Device Facts

- **Applicant:** Alive, Inc.
- **Product Code:** [IPF](/productcode/IPF.md)
- **Decision Date:** May 11, 1998
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 890.5850
- **Device Class:** Class 2
- **Review Panel:** Physical Medicine
- **Attributes:** Therapeutic

## Indications for Use

For adjunctive use in post-traumatic pain syndromes; for management and symptomatic relief of chronic (long term) pain; as an adjunctive treatment in the management of post surgical pain an adjust relaxation of muscle spasms; prevention or retardation of tissue atrophy; increasing blood circulation; muscle re-education; immediate post-surgical stimulation of calf muscles to prevent phlebothrombosis; and maintaining or increasing range of provide philosouncemes , al nerves for the purpose of providing pain relief and to stimulate motor nerves for the purpose of muscle rehabilitation.

## Device Story

Hakomed Elecdt/ProElecdt Series is an electrical stimulation device used for pain management and muscle rehabilitation. It delivers electrical impulses to nerves and muscles to provide pain relief and stimulate motor nerves for rehabilitation purposes. The device is intended for clinical use by healthcare professionals. It functions by applying electrical stimulation to target areas, aiding in muscle re-education, increasing circulation, and preventing atrophy or phlebothrombosis. The output is controlled electrical stimulation, which the clinician adjusts based on the patient's therapeutic needs. By facilitating muscle activity and modulating pain signals, the device assists in recovery from surgery or trauma and helps manage chronic pain conditions.

## Clinical Evidence

No clinical data provided; substantial equivalence based on regulatory review of intended use and device classification.

## Technological Characteristics

Electrical stimulation device; provides nerve and muscle stimulation for pain relief and rehabilitation. Technical specifications and materials not detailed in the provided documentation.

## Regulatory Identification

A powered muscle stimulator is an electrically powered device intended for medical purposes that repeatedly contracts muscles by passing electrical currents through electrodes contacting the affected body area.

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAY || | 10988

Mr. Kai Hansjurgens Alive Inc. 537 Cummins Street Honolulu, Hawaii 96814

Re : K980892 Hakomed Elecdt/Pro Eledt Series Trade Name: Requlatory Class: II Product Codes: IPF and LIH Dated: March 5, 1998 Received: March 9, 1998

## Dear Mr. Hansjurgens:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. ਰੇ substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{1}------------------------------------------------

## Page 2 - Mr. Kai Hansjurgens

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of vicio diagnobero actions, productionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

510(k) NUMBER (IF KNOWN) : K980892

DEVICE NAME: HAKOMED ELECDT/PROELECDT SERIES

## INDICATIONS FOR USE:

For adjunctive use in post-traumatic pain syndromes; for management and symptomatic relief of chronic (long term) pain; as an adjunctive treatment in the management of post surgical pain an adjust relaxation of muscle spasms; prevention or retardation of tissue atrophy; increasing blood circulation; muscle re-education; immediate post-surgical stimulation of calf muscles to prevent phlebothrombosis; and maintaining or increasing range of provide philosouncemes , al nerves for the purpose of providing pain relief and to stimulate motor nerves for the purpose of muscle rehabilitation.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED.)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter-Use
(Optional Format 1-2-96)

(Division Sign-Off)
Division of General Restorative Devices
510(k) Number K980892

---

**Source:** [https://fda-staging.innolitics.com/device/K980892](https://fda-staging.innolitics.com/device/K980892)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com